UGT2B15 Inhibitors [MoA] - N0000191274

Pharmacologic Class Information

Pharmacologic Code N0000191274
Pharmacologic Name UGT2B15 Inhibitors
Pharmacologic Uses
  • thrombopoietin receptor agonist
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with UGT2B15 Inhibitors

The following table contains 6 products whose active ingredient are classified under the same pharmacologic class UGT2B15 Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0078-0684Promacta Non-Proprietary Name: Eltrombopag OlamineTablet, Film CoatedOralNovartis Pharmaceuticals CorporationACTIVE
0078-0685Promacta Non-Proprietary Name: Eltrombopag OlamineTablet, Film CoatedOralNovartis Pharmaceuticals CorporationACTIVE
0078-0686Promacta Non-Proprietary Name: Eltrombopag OlamineTablet, Film CoatedOralNovartis Pharmaceuticals CorporationACTIVE
0078-0687Promacta Non-Proprietary Name: Eltrombopag OlamineTablet, Film CoatedOralNovartis Pharmaceuticals CorporationACTIVE
0078-0697Promacta Non-Proprietary Name: Eltrombopag OlaminePowder, For SuspensionOralNovartis Pharmaceuticals CorporationACTIVE
0078-0972Promacta Non-Proprietary Name: Eltrombopag OlaminePowder, For SuspensionOralNovartis Pharmaceuticals CorporationACTIVE